Highlightll Pharma
Series C in 2025
HighlightLL Pharma is a pharmaceutical company focused on developing drugs for immune diseases and tumors. The company is dedicated to creating innovative product lines that possess global competitive advantages. By leveraging its unique pharmacological, biological, and clinical capabilities, HighlightLL Pharma aims to provide patients with safe and affordable treatment options.
SENASIC is a company based in Shanghai, China, founded in 2015, specializing in the research, development, manufacture, and supply of advanced sensors and high-performance chips for automotive and industrial Internet of Things (IoT) applications. The company's primary focus is on automotive tire pressure monitoring sensors, including models that measure pressure, temperature, radial acceleration, and power supply voltage. SENASIC also develops a range of other sensors, such as MAN sensors and industrial-grade wireless temperature sensors. With a strong emphasis on low-power microcontroller technology, high-precision analog-to-digital converters, and reliable chip packaging and testing processes, SENASIC has established a reputation for producing high-quality products that meet automotive standards. Their tire pressure sensors have achieved AEC-Q10 certification, reflecting the company's commitment to enhancing vehicle safety and reliability through innovative sensor solutions.
Huali Juneng
Seed Round in 2024
Huali Juneng is a pressure vessel and related equipment producer specializing in petroleum, chemical, oil, electricity, desalination, and medical.
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment.
Mellow Energy
Seed Round in 2024
Mellow Energy Technology is a new calcium ore photovoltaic cell enterprise. Its business is the research and development, production and sales of centralized and distributed photovoltaic power stations.
AnDiConBio
Series A in 2024
AnDiConBio is a pharmaceutical company focused on developing respiratory anti-infection drugs. The company has created a diverse product pipeline that includes innovative treatments for influenza and oral medications targeting new coronavirus infections. AnDiConBio aims to deliver high-potential and low-risk products, ensuring that its offerings are both safe and effective for patients. By concentrating on respiratory infections, the company seeks to address significant health challenges and improve therapeutic options in this critical area of healthcare.
Arnatar Therapeutics
Series A in 2024
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Innovo Therapeutics
Seed Round in 2023
Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown.
Baoling Bio
Series B in 2023
Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia.
Huaqing Electronic Material
Series C in 2023
Huaqing Electronic Material is a leading manufacturer specializing in the research, development, production, and sales of high-performance aluminum nitride ceramic substrates. These substrates exhibit exceptional thermal conductivity, low dielectric properties, and robust mechanical strength. Huaqing's products cater primarily to high-tech industries such as 5G communications, aerospace, automotive electronics, and semiconductors, both domestically and internationally. The company employs tape-casting manufacturing processes to ensure the quality of its ceramic substrates, which are renowned for their reliability and affordability in various applications.
Anmuquan Intelligent Technology
Series C in 2023
Anmuquan Intelligent Technology specializes in providing innovative packaging solutions and software specifically for integrated circuits, including semiconductor components. The company focuses on addressing the needs of the semiconductor industry by offering packaging services for essential components such as central processing units, digital signal processors, and image processors. By enhancing the independent production capabilities within the semiconductor sector, Anmuquan Intelligent Technology aims to support the industry's pursuit of self-sufficiency in core component manufacturing.
OptoMedic
Debt Financing in 2023
OptoMedic is a company focused on the research, development, and production of advanced optical medical devices and systems. It specializes in medical fluorescence navigation endoscopes that leverage aerospace and military optical technology for medical applications. Its product portfolio includes endoscopic monitoring equipment, cancer screening tools, endoscopic navigation systems, and fluorescent imaging systems. These innovations are designed to enhance the ability of medical institutions and healthcare professionals to effectively assess and monitor patient conditions.
Zhongke Hydroyi
Angel Round in 2023
Zhongke Hydroyi focuses on the research and development of polymer diaphragm products.
Eccogene is a clinical stage biopharmaceutical company focused on developing therapeutic solutions for unmet medical needs, particularly in the areas of metabolic and immune-related diseases. The company specializes in disease biology, medicinal chemistry, and translational science, with the aim of creating innovative pharmaceuticals that target complex chronic conditions such as obesity and diabetes. Eccogene is dedicated to advancing its pipeline of metabolic drugs to enhance patient outcomes and address significant health challenges.
Singularity Energy Technology
Series B in 2023
Singularity Energy is committed to core technology research and product development in advanced energy storage systems, and contributes industry-leading solutions to promote large-scale clean energy integration and achieve global carbon neutrality goals.
Yuefang Technology
Series A in 2023
Yuefang Technology is a chip design company initiated and established by Galanz Group.
Hygea Medical
Series D in 2023
Hygea Medical Technology Co. Ltd. is a Beijing-based company specializing in the design and manufacture of medical devices aimed at oncology treatments. The company develops anti-tumor treatment equipment, including cryosurgery and cryopreservation devices. Hygea's solutions are specifically tailored to address various cancers, including those affecting the lung, liver, breast, and kidney. The company is committed to advancing its micro-invasive technologies and Cryo-HITTM technology to enhance treatment efficiency for patients with tumor diseases. Through its innovative approach, Hygea Medical aims to improve the effectiveness of cancer therapies.
Genepoint Biological Technology
Series D in 2023
Genepoint Biological Technology, based in Shanghai, China, specializes in manufacturing and distributing advanced devices for cryogenic biomaterial storage and handling. Their product portfolio includes automated cryo-bio storage systems, hybrid cryo-storage solutions, LIN vapor freezers, and specialized hoists for freezers, catering to life sciences researchers. The company is committed to advancing IoT, automation, and intelligence technologies in the field of cryogenic biomaterial management.
Aiste
Venture Round in 2023
Aiste provides power conversion solutions. They offers SiC MOS chips and SiC modules for vehicles, motor drives, charging piles, wind energy inverters, photovoltaic inverters, and industrial power supplies.
Haawking is a Chinese company that specializes in the development and manufacturing of digital signal processors and microprocessors. The company offers products tailored for various applications, including industrial control, motor drives, digital power supplies, photovoltaic systems, energy storage, new energy automotive, and consumer electronics. Haawking emphasizes research and development, aiming to enhance computing efficiency and reduce costs for its clients. Its product line also includes machine vision chips designed for use in industrial robots and intelligent applications such as augmented reality and autonomous driving. Customers can reach out to the company through provided contact information.
Vivolight
Series D in 2022
Founded in 2012, Vivolight is a medical device company incubated and supported by Xi'an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. We are headquartered in Shenzhen and have established an R&D center in Xi’an. Rooted in the field of medical laser technology, we are committed to the independent development, global innovation and independent manufacturing of medical devices used for minimally invasive interventional diagnosis and treatment with the technology of laser by leveraging the world-leading photoelectric technology and combining medicine and engineering. In April 2020, our self-developed optical coherence tomography (OCT) system obtained the approval of NMPA and achieved commercialization. In December 2021, our innovative Multimodality OCT System was approved by NMPA. It is the first Multimodality OCT System in the field of coronary artery OCT that has been approved for clinical application. In the field of interventional laser therapy, we have multiple products that have entered the phase of pre-clinical study.
Beilai Bio
Series B in 2022
Beilai Bio is a clinical-stage biopharmaceutical company focused on the development of stem cell therapeutics for various diseases, particularly those with high unmet medical needs. Its established technology platforms allow them to produce clinical-grade "off-the-shelf" Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC) from an unlimited supply of cord tissues that are traditionally regarded as medical waste.
Zhide New Energy
Series B in 2022
Zhide New Energy is a developer of approaches to synthetize new silicon anode materials. They focuses on silicon technology that can be applied to produce new materials. They also produce battery with high energy density and low cost. They manufactures battery for 3C and EV. They provide batteries for fields, such as electric vehicles, consumer electronics, house power storage, and wearable devices.
Sunwoda Electronic
Post in 2022
Sunwoda Electronic is a high-tech enterprise specializing in the research and development, design, production, and sale of lithium-ion battery cells and modules. The company offers a diverse range of products, including batteries for mobile phones, digital cameras, laptops, netbooks, electronic paper books, power-driven tools, industrial mobile lighting, and medical equipment. Sunwoda is dedicated to providing eco-friendly and efficient energy-integrated solutions, positioning itself as a key player in the battery industry.
CYGNUSEMI
Series A in 2022
Cygnus Semi is a semiconductor chip technology company that specializes in developing solutions for 5G Internet-of-Things (IoT) applications. The company focuses on creating advanced connectivity capabilities for smart devices and smart cities. Its products are designed to enhance the performance of electronic devices, allowing manufacturers to integrate high-quality chip technology into their smart products. Through its innovations, Cygnus Semi aims to support the growing demand for enhanced connectivity in various sectors.
Guizhou Core Long March Technology (Marching Power)
Series C in 2021
Guizhou Core Long March Technology, also known as Marching Power, is a high-tech company focused on the development of power semiconductor devices. Its product portfolio includes IGBT, coolmos, and SiC chip technologies, which are designed to operate under varying temperatures and voltages. The company's technical team comprises experts from the Chinese Academy of Sciences and skilled professionals from abroad, boasting substantial experience in product development. They oversee the entire process from chip design to manufacturing, packaging, testing, and reliability. Additionally, the company has a proficient marketing and operations management team well-versed in the semiconductor industry. Through its commitment to localizing power chip production, Guizhou Core Long March Technology aims to enable various enterprises to integrate high-quality semiconductors into their electronic products effectively.
Creative Technology
Venture Round in 2021
Creative Technology focuses on the surface treatment technology and product fields of wet electronic materials.
MingMed is a Chinese pharmaceutical company focused on independent drug research and development, demonstrating strong global competitiveness. The company specializes in a diverse product pipeline that includes ophthalmic drugs, recombinant protein botulinum toxin, tumor immune drugs, and immune therapies for pets. MingMed also emphasizes innovation, with several potential First-in-Class drugs currently in the clinical stage. Its research spans various therapeutic areas, delivering cutting-edge solutions in ophthalmology, medical aesthetics, and veterinary medicine, particularly through small molecule immune drugs and gene editing-based cell therapies.
Gokin Solar
Angel Round in 2021
Gokin Solar specializes in the research and development, as well as the manufacturing, of high-efficiency large-size photovoltaic silicon wafers and monocrystalline silicon rods. Its product range includes 182mm and 210mm monocrystalline silicon rods and wafers, which are essential components in photovoltaic systems. These products are primarily utilized in large ground-based centralized power plants, as well as in industrial, commercial, and residential photovoltaic applications. By providing high-performance and high-quality silicon wafers, Gokin Solar supports enterprises within the photovoltaic industry in enhancing their energy solutions.
Guangzhou WeRide Technology Co., Ltd. specializes in developing autonomous driving technology for level 4 vehicles, including its own hardware solutions that ensure comprehensive sensor coverage. Founded in 2017 and headquartered in Guangzhou, China, WeRide has established research and development centers across several major cities in China, as well as in Silicon Valley. The company has received strategic investments from leading global automotive groups and holds the distinction of being the first startup to obtain driverless test permits in both China and the United States. In November 2019, WeRide launched its first publicly accessible Robotaxi service in Guangzhou, which covers an area of 144 square kilometers and has since integrated with Amap, a popular ride-hailing app in China. The service has completed over 147,000 trips for more than 60,000 passengers within its first year. WeRide's offerings include a range of autonomous vehicles, such as Robotaxis, Robobuses, and Robovans, and the company continues to focus on enhancing safety and efficiency in transportation.
Norson Biotechnology
Series B in 2020
Norson Biotechnology produces edible probiotic powder, probiotic solid beverages, fermented lactic acid bacteria beverages, and other products.
MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013, the company operates from its headquarters in Yantai, China, and has an additional office in Fremont, California. MabPlex provides a comprehensive range of services that encompass all stages of drug development, from DNA to finished drug products. Its offerings include customized mammalian cell medium, cell banking, and the manufacturing of monoclonal antibody active pharmaceutical ingredients, as well as fill and finish services for biologics and antibody-drug conjugates. The company aims to deliver high-quality solutions for bio-manufacturing to its global partners.
Jianghan New Materials
Series A in 2020
Jianghan New Materials is a producer of silane coupling agents, crosslinking agents, and intermediates. Their products include chlorosilane intermediate and the silane series. alkylsilane, alkoxysilane intermediate, sulfur-containing silane, ami+, phenylsilane, acyloxysilane, epoxy silane, and vinylsilane
Kingsware
Series A in 2020
Kingsware is a developer of robotic process automation (RPA) software aimed at enhancing operational efficiency for businesses in various sectors, including finance and production. The company specializes in creating an enterprise-level robot management platform that emphasizes safety, ease of use, and robust performance. Its RPA system automates repetitive tasks and business operations, allowing enterprises to streamline processes in production, finance, and supply chain management. Kingsware's solutions are designed for deployment in large-scale, highly integrated environments, ensuring stability and efficiency across complex organizational frameworks.
Mabwell Biotech
Series A in 2020
Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.
Suzhou Kintor Pharmaceuticals
Series D in 2019
Suzhou Kintor Pharmaceuticals is a biopharmaceutical company established in 2009, primarily engaged in the research and development of innovative drugs targeting various cancers and androgen receptor-related diseases. Headquartered in Suzhou, China, the company focuses on addressing significant unmet medical needs in conditions such as metastatic castration-resistant prostate cancer, breast cancer, and liver cancer, which collectively represent a substantial portion of the global cancer burden. Kintor's leading drug candidates include Proxalutamide, currently undergoing clinical trials for prostate and breast cancer, and Pyrilutamide, which targets androgenetic alopecia and acne vulgaris. The company also develops several other drug candidates, including ALK-1 for liver cancer and Detorsertib, a second-generation mTOR inhibitor for metastatic solid tumors. Kintor's extensive product pipeline is built on proprietary research and development, aiming to deliver both “best-in-class” and “first-in-class” therapeutic options to patients in need.
Insta360 is a technology company based in Shenzhen that specializes in innovative camera solutions designed to enhance how users capture and share experiences. Established in 2014, the company has emerged as a leader in the 360-degree camera market, offering a range of products tailored for various needs, including professional creators and casual users. Their offerings include lightweight portable cameras, mobile phone attachments, cameras specifically designed for vlogging, and advanced VR cinematic cameras. These products enable high-definition 360-degree photos and videos, allowing users to live-stream their experiences on major social media platforms. Through its commitment to performance and accessibility, Insta360 empowers users to relive and share their moments in immersive detail, particularly when experienced through virtual reality headsets.
Das Security
Venture Round in 2017
Das Security is a provider of information security technology services, offering many comprehensive solutions like application security, database security, website security monitoring, and a digital security management platform. The company maintains its corporate purpose of creating a safe and credible digital world, supports, customer success, responsibility first, open innovation, and people-oriented, common growth as the company's values, and positions itself as the security cornerstone of digitalization. It is committed to leading the global digital security industry.